Friday, April 17, 2026
10:00 a.m. to 4:30 p.m. ET
Online Only
« Back to Workshop Page
«« See Day 1: April 15, 2026
« See Day 2: April 16, 2026
10:00 a.m.
Opening Remarks and Day 2 Recap
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair
NIH Leadership Remarks
10:10 a.m.
National Institute of Mental Health
Andrea Beckel-Mitchener, Ph.D.
Acting Director, National Institute of Mental Health
National Institutes of Health
10:15 a.m.
National Heart, Lung, and Blood Institute
David Goff, M.D., Ph.D.
Acting Director, National Heart, Lung, and Blood Institute
National Institutes of Health
Key Question 2a:
What is the impact of individual-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms? Individual-level factors include, but are not limited to, educational attainment, patient engagement in health care, lifestyle factors, and comorbidities.
10:20 a.m.
Moderator Perspectives: How Do Individual-Level Factors Influence the Likelihood of Perimenopausal and Early Postmenopausal Women with Symptoms Receiving Treatment?—Genevieve Neal-Perry, M.D., Ph.D.
10:30 a.m.
Closing the Menopause Care Gap: The Workforce Issue—Rajita G. Patil, M.D.
10:50 a.m.
Patient Education: Menopause Preparedness—Irene Aninye, Ph.D.
11:10 a.m.
Awareness/Communications—Jennifer Gunter, M.D
11:30 a.m.
It Takes a Village: Perspectives on Menopausal Care Empowerment, Advocacy, and Community Engagement—Genevieve Neal-Perry, M.D., Ph.D
11:50 a.m.
Discussion
Moderated by
Genevieve Neal-Perry, M.D., Ph.D.
12:10 p.m.
Lunch Break
Key Question 2b:
What is the impact of system-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms? System-level factors include, but are not limited to, racism, provider bias, access to care, and social determinants of health. Do the effectiveness, comparative effectiveness, and harms of treatment vary by individual- or system-level factors?
12:40 p.m.
System-Level Challenges Affecting the Menopause Experience and Quality of Care for Midlife Women: Research Gaps and Reflections on Solutions—Andrea LaCroix, Ph.D.
1:00 p.m.
Regulatory Perspectives: Opportunities and Considerations—Janet Maynard, M.D.
1:20 p.m.
Social and Cultural Context of Menopause—Yamnia Cortes, Ph.D., M.P.H., R.N., FAHA, FAAN
1:40 p.m.
Discussion
Moderated by
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair
2:00 p.m.
Break
General Session 3
Innovative Approaches to Symptom Prevention and Management: Walk Before We Run—Grounding Innovation in Evidence for Menopause Care
2:10 p.m.
Moderator Perspectives—Melissa S. Wong, M.D., M.H.D.S.
2:20 p.m.
Data Gaps & the DREAM Registry… and Other Data Sets—Stephanie S. Faubion, M.D., M.B.A.
2:35 p.m.
Women’s Sexual Health and Direct-to-Consumer Approaches—Lyndsey Harper, M.D.
2:50 p.m.
Health Policy and Digital Innovation Readiness—Barbara Levy, M.D., FACOG, FACS
3:05 p.m.
The Etiology of Online Medical Misinformation—Jevin West, Ph.D.
3:20 p.m.
Discussion
Moderated by
Melissa S. Wong, M.D., M.H.D.S.
3:40 p.m.
Break
3:50 p.m.
Roundtable on What We Learned, What Comes Next?
Moderated by
Sarah Temkin, M.D.
- Nanette Santoro, M.D.
- Karen Giblin
- Genevieve Neal-Perry, M.D., Ph.D.
- Melissa S. Wong, M.D., M.H.D.S.
4:20 p.m.
Closing Remarks & Next Steps
Cheryl Anderson, Ph.D., M.P.H., M.S
Workshop & Panel Chair
Keisha L. Shropshire, M.P.H.
P2P Workshop Coordinator
4:30 p.m.
Adjourn